Answer
Pemigatinib's licensed role requires an FGFR2 fusion or rearrangement in the tumour, so this must be confirmed with an appropriate diagnostic test.
Sources for this answer
- Pemazyre 4.5 mg - tablets — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.